NATIONAL NUCLEAR RESEARCH CENTER CJSC UNDER MINISTRY OF TRANSPORT, COMMUNICATIONS AND HIGH TECHNOLOGIES OF THE REPUBLIC OF AZERBAIJAN

Their core work

NNRC is a state-affiliated research institution in Baku, Azerbaijan, operating under the Ministry of Transport, Communications and High Technologies. Despite its "nuclear" designation in the formal name, its H2020 engagement spans materials science, energy harvesting, and biomedical nanomaterials — suggesting the center applies broad experimental and analytical research capacity beyond nuclear applications. In EU projects, it participates exclusively as a third party through MSCA-RISE staff exchange mechanisms, meaning it serves as a sending or hosting institution for researcher mobility rather than a direct budget-holding partner. Its two projects point to laboratory-level expertise in materials characterization, in vitro and in vivo testing, and the study of nanomaterials for biomedical and energy applications.

What they specialise in

How they've shifted over time

NNRC's first H2020 involvement (SSHARE, 2019) was in clean energy materials — specifically adsorption-based humidity energy harvesting — where keyword data is sparse, suggesting a supporting or hosting role. By 2021, the center shifted toward biomedical nanomaterials, with PhytoAPP bringing a substantially richer keyword profile: phytochemicals, amyloid fibrils, toxicity, and bioactivity testing. This pivot from energy-adjacent materials to neurodegenerative disease prevention is notable and may reflect the center's broader analytical infrastructure being redirected toward biomedical questions, or active recruitment of researchers with those profiles through MSCA-RISE exchanges.

NNRC appears to be repositioning toward biomedical materials research — particularly phytochemical compounds and amyloid-targeting nanomaterials — which suggests future collaborations in drug discovery, biomaterials, or precision medicine would be a stronger fit than energy-focused consortia.

How they like to work

NNRC has never led an H2020 project and participates exclusively as a third party, receiving no direct EC funding — a pattern typical of institutions in non-EU Associated Countries that join MSCA-RISE consortia to exchange researchers. Despite this limited formal role, they have built a network of 16 partners across 11 countries through just two projects, indicating participation in medium-to-large international consortia. Potential partners should expect NNRC to contribute research capacity (lab access, researcher time) rather than project management or funding administration.

Through two MSCA-RISE projects, NNRC has connected with 16 distinct consortium partners spanning 11 countries, suggesting active participation in well-networked European research exchanges rather than isolated bilateral arrangements. No repeated partner pattern is visible with only two data points.

What sets them apart

NNRC is one of very few Azerbaijani research institutions visible in the H2020 dataset, giving it rare value as a gateway to the South Caucasus scientific community for consortium builders who need a non-EU third-country partner. Its combination of a state nuclear research infrastructure (implying broad analytical equipment) with active engagement in biomedical nanomaterials and phytochemistry creates an unusual profile that bridges physical sciences and life sciences. For MSCA-RISE applications specifically, it offers a credible non-EU mobility destination with government backing and cross-disciplinary research capacity.

Highlights from their portfolio

• PhytoAPP
  The most technically detailed of the two projects, addressing Alzheimer's and Parkinson's prevention via phytomaterial nanomaterials — a high-impact disease area with strong industry interest — and running through 2026, meaning the collaboration is still active.
• SSHARE
  An early clean-energy project (2019) that placed NNRC in a sustainability-focused MSCA-RISE network, demonstrating the center's willingness to contribute to applied energy challenges outside its nuclear mandate.